Form 8-K - Current report:
SEC Accession No. 0001193125-25-137954
Filing Date
2025-06-10
Accepted
2025-06-09 17:49:41
Documents
13
Period of Report
2025-06-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d46354d8k.htm   iXBRL 8-K 47699
2 EX-3.1 d46354dex31.htm EX-3.1 5946
  Complete submission text file 0001193125-25-137954.txt   175628

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA caba-20250609.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20250609_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20250609_pre.xml EX-101.PRE 11717
15 EXTRACTED XBRL INSTANCE DOCUMENT d46354d8k_htm.xml XML 3844
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: AZ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 251035283
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)